FANHDI 100 IUML 1500 IU (FACTOR VIII) Israel - English - Ministry of Health

fanhdi 100 iuml 1500 iu (factor viii)

medici medical ltd, israel - factor viii (human) - powder for solution for injection - factor viii (human) 1500 iu/dose - factor viii inhibitor bypassing activity - factor viii inhibitor bypassing activity - is indicated for the prevention and control of bleeding in patients with moderate or severe factor viii deficiency due to classical hemophilia a . fanhdi is not effective in controlling the bleeding of patients with von willebrond's disease.

Optivate 250 IU powder and solvent for solution for injection, Human coagulation factor VIII Malta - English - Medicines Authority

optivate 250 iu powder and solvent for solution for injection, human coagulation factor viii

bio products laboratory limited - factor viii, human; von willebrand factor, human - powder and solvent for solution for injection - factor viii, human 250 iu; von willebrand factor, human 430 iu - antihemorrhagics

Optivate 500 IU powder and solvent for solution for injection, Human coagulation factor VIII Malta - English - Medicines Authority

optivate 500 iu powder and solvent for solution for injection, human coagulation factor viii

bio products laboratory limited - factor viii, human; von willebrand factor, human - powder and solvent for solution for injection - factor viii, human 500 iu; von willebrand factor, human 860 iu - antihemorrhagics

Optivate 1000 IU powder and solvent for solution for injection, Human coagulation factor VIII Malta - English - Medicines Authority

optivate 1000 iu powder and solvent for solution for injection, human coagulation factor viii

bio products laboratory limited - factor viii, human; von willebrand factor, human - powder and solvent for solution for injection - factor viii, human 1000 iu; von willebrand factor, human 1720 iu - antihemorrhagics

FANHDI 25 IUML (FACTOR VIII) Israel - English - Ministry of Health

fanhdi 25 iuml (factor viii)

medici medical ltd, israel - factor viii (human) - powder for solution for injection - factor viii (human) 250 iu - coagulation factor viii - coagulation factor viii - is indicated for the prevention and control of bleeding in patients with moderate or severe factor viii deficiency due to classical hemophilia a .fanhdi is not effective in controlling the bleeding of patients with von willebrond's disease.

FANHDI 50 IUML (FACTOR VIII) Israel - English - Ministry of Health

fanhdi 50 iuml (factor viii)

medici medical ltd, israel - factor viii (human) - powder for solution for injection - factor viii (human) 500 iu - coagulation factor viii - coagulation factor viii - is indicated for the prevention and control of bleeding in patients with moderate or severe factor viii deficiency due to classical hemophilia a . fanhdi is not effective in controlling the bleeding of patients with von willebrond's disease.

FANHDI 100 IUML (FACTOR VIII) Israel - English - Ministry of Health

fanhdi 100 iuml (factor viii)

medici medical ltd, israel - factor viii (human) - powder for solution for injection - factor viii (human) 1000 iu - coagulation factor viii - coagulation factor viii - is indicated for the prevention and control of bleeding in patients with moderate or severe factor viii deficiency due to classical hemophilia a . fanhdi is not effective in controlling the bleeding of patients with von willebrond's disease.

Wilate 500, 500 IU VWF/500 IU FVIII, powder and solvent for solution for injection Malta - English - Medicines Authority

wilate 500, 500 iu vwf/500 iu fviii, powder and solvent for solution for injection

octapharma (ip) sprl alle de la recherche 65, 1070 (anderlecht), belgium - human von, willebrand factor, human coagulation, factor viii - powder and solvent for solution for injection - human von willebrand factor 500 iu human coagulation factor viii 500 iu - antihemorrhagics